[Occurrence of antibodies against transcobalamin II in relation to the number of and the intervals between depot therapy with hydroxocobalamin].
作者信息
Hippe E, Olesen H, Skouby A
出版信息
Nord Med. 1970 Dec 3;84(49):1570.
PMID:5488577
Abstract
摘要
相似文献
1
2
Hydroxocobalamin for initial and long-term therapy for vitamin B12 deficiency.羟钴胺用于维生素B12缺乏的初始及长期治疗。
Acta Med Scand. 1987;221(4):399-402. doi: 10.1111/j.0954-6820.1987.tb03362.x.
3
Retention of cyanocobalamin, hydroxocobalamin, and coenzyme B12 after parenteral administration.肠胃外给药后钴胺素、羟钴胺素和辅酶B12的保留情况。
Lancet. 1968 Sep 28;2(7570):710-2. doi: 10.1016/s0140-6736(68)90752-6.
4
Optimizing the dose of hydroxocobalamin in cobalamin C (cblC) defect.优化钴胺素C（cblC）缺陷中羟钴胺素的剂量。
Mol Genet Metab. 2013 Aug;109(4):329-30. doi: 10.1016/j.ymgme.2013.05.013. Epub 2013 May 29.
5
Hydroxocobalamin and its long-acting effects in treatment of vitamin B 12 deficiency.羟钴胺及其在治疗维生素B12缺乏症中的长效作用。
Pharmakotherapia. 1964;2(1):21-58.
6
Hereditary partial transcobalamin II deficiency with neurologic, mental and hematologic abnormalities in children and adults.儿童及成人遗传性部分转钴胺素II缺乏伴神经、精神及血液学异常
Isr Med Assoc J. 2003 Dec;5(12):868-72.
7
Hydroxocobalamin and cyanocobalamin.羟钴胺素和氰钴胺素。
Drug Ther Bull. 1966 Feb 4;4(3):11-2.
8
Retention and distribution of B12 activity, and requirement for B12, following parenteral administration of hydroxocobalamin (Vibeden).注射羟钴胺素（Vibeden）后维生素B12活性的保留与分布以及对维生素B12的需求
Acta Med Scand. 1966 Jul;180(1):95-105. doi: 10.1111/j.0954-6820.1966.tb02812.x.
9
Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients.鼻内给予羟钴胺使维生素B12缺乏患者血浆维生素B12浓度正常化。
Gastroenterology. 1997 Aug;113(2):430-3. doi: 10.1053/gast.1997.v113.pm9247460.
10
Hydroxocobalamin for cobalamin C: which dosage?用于钴胺素C的羟钴胺素：何种剂量？
J Inherit Metab Dis. 2010 Aug;33(4):453; author reply 455. doi: 10.1007/s10545-010-9068-8. Epub 2010 Mar 12.
Zotero 插件